High-Intensity Exercise for Type 1 Diabetes
(FEEL-HIIT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if adding high-intensity interval training to standard diabetes education helps people with type 1 diabetes better recognize low blood sugar. Participants will either follow the educational program alone or combine it with home-based exercise sessions (Home-based High Intensity Interval Training). Individuals who have had type 1 diabetes for at least five years and struggle to notice low blood sugar may be suitable candidates. The goal is to enhance their awareness and safety by reducing episodes of low blood sugar. As an unphased trial, this study provides a unique opportunity to contribute to innovative diabetes management strategies.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must be on a stable type of insulin for at least one month before joining. If you're not using an insulin analog, you may need to switch to one at least a month before starting the trial.
What prior data suggests that high-intensity interval training is safe for people with type 1 diabetes?
Research has shown that high-intensity interval training (HIIT) can be safely performed by people with type 1 diabetes. A review found that low-volume HIIT, such as the kind done at home, is generally manageable. One study examined a virtual home-based HIIT program for individuals with type 1 diabetes and demonstrated that participants could safely engage in this exercise without major issues.
Specifically, home-based HIIT may help reduce the fear of low blood sugar (hypoglycemia) and overcome other exercise barriers. This suggests that the training not only improves fitness but is also safe for those concerned about low blood sugar.
In summary, high-intensity interval training, when conducted at home and monitored online, appears to be a safe option for people with type 1 diabetes, with no significant problems reported in these studies.12345Why are researchers excited about this trial?
Researchers are excited about the high-intensity exercise program for Type 1 Diabetes because it offers a unique, home-based approach to managing this condition. Unlike traditional methods that primarily focus on medication and dietary management, this program integrates High Intensity Interval Training (HIIT) to potentially improve blood sugar control. By incorporating short bursts of intense exercise with periods of rest, this method could enhance insulin sensitivity and glucose regulation, offering a new, active way to complement existing treatments. Plus, its home-based nature makes it more accessible and convenient, encouraging regular participation and long-term lifestyle changes.
What evidence suggests that this trial's treatments could be effective for type 1 diabetes?
Research shows that high-intensity interval training (HIIT) can help people with type 1 diabetes control blood sugar and improve heart health. In this trial, one group of participants will follow a home-based HIIT program combined with a standard educational program. Studies have found that doing HIIT at home can reduce the fear of low blood sugar and make exercise more accessible for people with diabetes. Other research has shown that HIIT can lower blood sugar after meals and decrease insulin levels. These benefits suggest that including HIIT in a diabetes management plan might help people better recognize and prevent low blood sugar episodes.13567
Who Is on the Research Team?
Rémi Rabasa-Lhoret
Principal Investigator
Institut de recherches cliniques de Montréal
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with type 1 diabetes and a reduced ability to detect low blood sugar, who've had diabetes for at least five years. They must use or be willing to use a continuous glucose monitor and have stable insulin treatment. Exclusions include heart rate-affecting meds, pregnancy, physical limitations preventing exercise, severe diabetic complications, recent high-intensity training, uncontrolled hypertension or significant heart disease.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to a 12-week program of standard educational program with or without high intensity interval training
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Home-based High Intensity Interval Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Institut de Recherches Cliniques de Montreal
Lead Sponsor